Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis. Rubin DT, Modesto I, Vermeire S, Danese S, et al. Aliment Pharmacol Ther 2021 Oct 9. doi: 10.1111/apt.16619.

Read + Share

Amedeo Smart

Independent Medical Education

Rubin DT, Modesto I, Vermeire S, Danese S, et al. Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis. Aliment Pharmacol Ther 2021 Oct 9. doi: 10.1111/apt.16619.
PMID: 34626429